These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28858832)

  • 1. Synthesis and photodegradation studies of analogues of muscle relaxant 1,4-dihydropyridine compounds.
    Gündüz MG; Ragno G; Şimşek R; De Luca M; Şafak C; Grande F; El-Khouly A; İşli F; Yildirim Ş; Öztürk Fincan GS; Ioele G
    Acta Pharm; 2017 Sep; 67(3):341-355. PubMed ID: 28858832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodegradation studies of 1,4-dihydropyridine compounds by MCR analysis on UV spectral data.
    Ioele G; Gündüz MG; De Luca M; Şimşek R; Şafak C; Muzzalupo R; Ragno G
    Future Med Chem; 2016; 8(2):107-15. PubMed ID: 26577373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photostabilization studies of antihypertensive 1,4-dihydropyridines using polymeric containers.
    De Luca M; Ioele G; Spatari C; Ragno G
    Int J Pharm; 2016 May; 505(1-2):376-82. PubMed ID: 27085645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of photosensitivity of 1,4-dihydropyridine antihypertensives by quantitative structure-property relationship.
    Ioele G; De Luca M; Oliverio F; Ragno G
    Talanta; 2009 Oct; 79(5):1418-24. PubMed ID: 19635379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker.
    Iman M; Davood A; Nematollahi AR; Dehpoor AR; Shafiee A
    Arch Pharm Res; 2011 Sep; 34(9):1417-26. PubMed ID: 21975802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.
    Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A
    Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
    Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
    Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents.
    Navidpour L; Miri R; Shafiee A
    Arzneimittelforschung; 2004; 54(9):499-504. PubMed ID: 15500195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.
    Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A
    Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1,2-dihydropyridyl in place of the 1,4-dihydropyridyl moiety.
    Soboleski DA; Li-Kwong-Ken MC; Wynn H; Triggle CR; Wolowyk MW; Knaus EE
    Drug Des Deliv; 1988 Feb; 2(3):177-89. PubMed ID: 2855573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 1,4-dihydropyridine calcium channel modulators having a diazen-1-ium-1,2-diolate nitric oxide donor moiety for the potential treatment of congestive heart failure.
    Velázquez C; Knaus EE
    Bioorg Med Chem; 2004 Jul; 12(14):3831-40. PubMed ID: 15210150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and calcium modulatory activity of 3-alkyloxy-carbonyl-4-(disubstituted)aryl-5-oxo-1,4,5,6,7,8-hexa-hydroquinoline derivatives.
    Simşek R; Oztürk GS; Vural IM; Gündüz MG; Sarioglu Y; Safak C
    Arch Pharm (Weinheim); 2008 Jan; 341(1):55-60. PubMed ID: 17994603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
    Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
    Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
    Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
    Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, evaluation of pharmacological activities and quantitative structure-activity relationship studies of a novel group of bis(4-nitroaryl-1,4-dihyropyridine).
    Miri R; Javidnia K; Hemmateenejad B; Tabarzad M; Jafarpour M
    Chem Biol Drug Des; 2009 Feb; 73(2):225-35. PubMed ID: 19207425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T; Kase N; Kita H; Uematsu T
    Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of a new class of 1,4-dihydropyridines having a hydroxamic ester group in position 3 with a potential calcium antagonistic activity.
    Inglesi M; Nicola M; Magnetti S
    Farmaco; 1990 Dec; 45(12):1327-40. PubMed ID: 2090142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of myorelaxant activity of 7-substituted hexahydroquinoline derivatives in isolated rabbit gastric fundus.
    Gündüz MG; Sevim Oztürk G; Vural IM; Simşek R; Sarioğlu Y; Safak C
    Eur J Med Chem; 2008 Mar; 43(3):562-8. PubMed ID: 17590241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of some novel 1,4-dihydropyridines as potential antitubercular agents.
    Trivedi A; Dodiya D; Dholariya B; Kataria V; Bhuva V; Shah V
    Chem Biol Drug Des; 2011 Nov; 78(5):881-6. PubMed ID: 21895982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4(5)-chloro-2-methyl-5(4)-imidazolyl substituent.
    Davood A; Khodarahmi G; Alipour E; Dehpour K; Amini M; Shafiee A
    Boll Chim Farm; 2001; 140(6):381-6. PubMed ID: 11822226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.